These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 8351927

  • 1. [Reducing blood pressure and modification of coronary risk factors by therapy with doxazosin].
    Hitzenberger G, Ganzinger U.
    Wien Klin Wochenschr; 1993; 105(13):371-6. PubMed ID: 8351927
    [Abstract] [Full Text] [Related]

  • 2. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 3. [Doxazosin in the treatment of light-to-moderate arterial hypertension in a non-comparative multicenter study].
    Pessina AC.
    Clin Ter; 1995 Jan; 146(1):3-12. PubMed ID: 7705011
    [Abstract] [Full Text] [Related]

  • 4. Usefulness of the alpha1-blocker doxazosin as a third-line antihypertensive drug.
    Ohta Y, Tsuchihashi T, Onaka U, Eto K, Ueno M.
    Hypertens Res; 2007 Apr; 30(4):301-6. PubMed ID: 17541208
    [Abstract] [Full Text] [Related]

  • 5. Selective alpha 1 inhibition with doxazosin in hypertensive smokers and non-smokers: haemodynamic and metabolic effects.
    Westheim A, Daae LN, Kierulf P, Brusletto B, Holme I, Syvertsen JO.
    J Hypertens Suppl; 1990 Sep; 8(5):S41-6. PubMed ID: 1981076
    [Abstract] [Full Text] [Related]

  • 6. Effect of doxazosin gastrointestinal therapeutic system on patients with uncontrolled hypertension: the ASOCIA Study.
    de Alvaro F, Hernández-Presa MA, ASOCIA Study.
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):271-6. PubMed ID: 16495766
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 8. [Efficacy and tolerance of doxazosin in the treatment of isolated systolic hypertension in hypertensive patients over 60 years of age].
    Calvo C, López E, Barrio E, Espejo J, Ruiz M, Vega A.
    An Med Interna; 1995 Mar; 12(3):122-6. PubMed ID: 7795118
    [Abstract] [Full Text] [Related]

  • 9. Doxazosin in hypertension: results of a general practice study in 4809 patients.
    Langdon CG, Packard RS.
    Br J Clin Pract; 1994 Mar; 48(6):293-8. PubMed ID: 7848789
    [Abstract] [Full Text] [Related]

  • 10. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH, Burgess ED, Assouline L, Vanjaka A.
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [Abstract] [Full Text] [Related]

  • 11. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [Abstract] [Full Text] [Related]

  • 12. [Doxazosin (alpha 1-adrenoreceptor antagonist) used in primary hypertension and it's beneficial effect on lipid metabolism].
    Sznajderman M, Chotkowska E, Peczkowska M, Sawicki M, Janaszek-Sitkowska H, Wiernikowska-Wegorek I, Galewicz A, Cybulska I.
    Kardiol Pol; 1993 Feb; 38(2):107-11. PubMed ID: 8230980
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Rahardjo D, Soebadi DM, Sugandi S, Birowo P, Djati W, Wahyudi I.
    Int J Urol; 2006 Nov; 13(11):1405-9. PubMed ID: 17083392
    [Abstract] [Full Text] [Related]

  • 14. [Doxazosin for the treatment of arterial hypertension].
    Mozzato MG, Semplicini A, Serena L, Valle R, Casolino P, Buzzaccarini F, Rubino N, Giusto M, Pessina AC.
    Cardiologia; 1990 Nov; 35(11):931-6. PubMed ID: 2151571
    [Abstract] [Full Text] [Related]

  • 15. Long-term follow-up study to evaluate the efficacy and safety of the doxazosin gastrointestinal therapeutic system in patients with benign prostatic hyperplasia with or without concomitant hypertension.
    Chung BH, Hong SJ.
    BJU Int; 2006 Jan; 97(1):90-5. PubMed ID: 16336335
    [Abstract] [Full Text] [Related]

  • 16. Doxazosin for benign prostatic hyperplasia: an open-label, baseline-controlled study in Korean general practice.
    Chung BH, Hong SJ, Lee MS.
    Int J Urol; 2005 Feb; 12(2):159-65. PubMed ID: 15733110
    [Abstract] [Full Text] [Related]

  • 17. [Randomized, comparative study to evaluate efficacy and safety of doxazosin versus nitrendipine in the treatment of mild to moderate hypertension].
    Sanz Guajardo D, Espejo Martínez J.
    An Med Interna; 1997 Jan; 14(1):15-9. PubMed ID: 9091027
    [Abstract] [Full Text] [Related]

  • 18. Doxazosin GITS versus standard doxazosin in mild to moderate hypertension.
    Calvo C, Gil-Extremera B, Gomez-Fernández P, Masramon X, Pueyo C, Armada B.
    Int J Cardiol; 2005 May 11; 101(1):97-104. PubMed ID: 15860390
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of the efficacy and tolerance of doxazosin vs. enalapril inaged patients with light to moderate arterial hypertension].
    Puddu P, Gallucci M, Curnis A, Pupita F, Ansuini R, Malacco E.
    Clin Ter; 1995 Dec 11; 146(12):801-10. PubMed ID: 8681500
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of essential arterial hypertension with hypercholesterolemia. Effects of an alpha-adrenergic blocker and an inhibitor of the angiotensin converting enzyme].
    Fernández Pinilla C, Luque Otero M, Martell Claros N, Alcázar de la Osa JM, Rodicio Díaz JL, Ruilope Urioste LM.
    Med Clin (Barc); 1993 Jun 26; 101(5):168-71. PubMed ID: 8332009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.